https://www.pharming.com/release-annual-report-2017/ https://www.pharming.com/downloads/Annual_Report_2017.pdf I look forward with confidence to continuing the upward story of Pharming in 2018, with salesincreasing further, a new exciting pipeline and new opportunities for enhanced shareholder value. Leiden, 28 March 2018 Sijmen de Vries Chief Executive Officer and Chairman of the Board of Management |
|
aus der Diskussion: | Pharming Group -- der absolute Traum für jeden Anleger ! Kursziel 1,50 € ! |
Autor (Datum des Eintrages): | Hangzhou61 (29.03.18 08:00:29) |
Beitrag: | 33 von 50 (ID:57418502) |
Alle Angaben ohne Gewähr © wallstreetONLINE |